Cargando…
Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality
BACKGROUND: Conduction disease and arrhythmias represent a major cause of mortality in myotonic muscular dystrophy type 1 (MMD1). Permanent pacemaker (PPM) implantation is the cornerstone of therapy to reduce cardiovascular mortality in MMD1. Cardiovascular magnetic resonance (CMR) studies demonstra...
Autores principales: | Cardona, Andrea, Arnold, William D., Kissel, John T., Raman, Subha V., Zareba, Karolina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498496/ https://www.ncbi.nlm.nih.gov/pubmed/31046780 http://dx.doi.org/10.1186/s12968-019-0535-6 |
Ejemplares similares
-
Myocardial T1 and T2 Mapping in Duchenne muscular dystrophy: characterization of late gadolinium Eenhancement
por: Soslow, Jonathan H, et al.
Publicado: (2016) -
Myocardial late gadolinium enhancement is associated with clinical presentation in Duchenne muscular dystrophy carriers
por: Wexberg, Paul, et al.
Publicado: (2016) -
Presence of late gadolinium enhancement in Duchenne muscular dystrophy patients is associated with age and global ventricular function
por: Hor, Kan N, et al.
Publicado: (2012) -
Patterns of late gadolinium enhancement in Duchenne muscular dystrophy carriers
por: Giglio, Vincenzo, et al.
Publicado: (2014) -
Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function
por: Hor, Kan N, et al.
Publicado: (2013)